Wolters Kluwer completes Prosoft transaction with Alterdata June 1, 2021 - Wolters Kluwer Tax & Accounting today announces that it has completed the previously disclosed combination of certain
KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced it will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 10:30 a.m. ET.
A live webcast of the presentation will be available on the Company s website at www.kalvista.com. An audio archive will be available on KalVista s website for 30 days following the presentations.
About KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially ta
Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Share:
BURLINGTON, Mass., May 13, 2021 (GLOBE NEWSWIRE) Flexion Therapeutics, Inc. (NASDAQ:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the RBC Capital Markets 2021 Virtual Global Healthcare Conference. The virtual fireside chat is scheduled to begin at 1:55 p.m. ET on Wednesday, May 19, 2021.
To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (NASDAQ:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company s core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.
Wolters Kluwer N.V.: Wolters Kluwer has acquired Vanguard Software
signed
.
Vanguard Software serves companies of all sizes across every major industry in more than 60 countries, helping them to improve forecasting, reduce overstocks, optimize inventory distribution, and reduce supply chain costs. Vanguard Predictive Planning solutions use artificial intelligence, algorithmic modeling, process automation, and a collaboration hub to enable companies to optimize and automate end-to-end supply chain planning. In 2021, the Vanguard Predictive Planning platform was ranked as a leader in Supply Chain Planning by Nucleus Research and received an honorable mention from Gartner.
Vanguard Software revenues derive from subscription-based cloud software (averaging approximately 55% of total revenues in recent years) and software-related professional implementation and consulting services. The company recorded total revenues of $7.2 million in 2020 (un-audited). While the COVID-19 pandemic c